Green tea catechins prevent low-density lipoprotein oxidation via their accumulation in low-density lipoprotein particles in humans

Nutr Res. 2016 Jan;36(1):16-23. doi: 10.1016/j.nutres.2015.10.012. Epub 2015 Nov 3.

Abstract

Green tea is rich in polyphenols, including catechins which have antioxidant activities and are considered to have beneficial effects on cardiovascular health. In the present study, we investigated the effects of green tea catechins on low-density lipoprotein (LDL) oxidation in vitro and in human studies to test the hypothesis that catechins are incorporated into LDL particles and exert antioxidant properties. In a randomized, placebo-controlled, double-blind, crossover trial, 19 healthy men ingested green tea extract (GTE) in the form of capsules at a dose of 1 g total catechin, of which most (>99%) was the gallated type. At 1 hour after ingestion, marked increases of the plasma concentrations of (-)-epigallocatechin gallate and (-)-epicatechin gallate were observed. Accordingly, the plasma total antioxidant capacity was increased, and the LDL oxidizability was significantly reduced by the ingestion of GTE. We found that gallated catechins were incorporated into LDL particles in nonconjugated forms after the incubation of GTE with plasma in vitro. Moreover, the catechin-incorporated LDL was highly resistant to radical-induced oxidation in vitro. An additional human study with 5 healthy women confirmed that GTE intake sufficiently increased the concentration of gallated catechins, mainly in nonconjugated forms in LDL particles, and reduced the oxidizability of LDL. In conclusion, green tea catechins are rapidly incorporated into LDL particles and play a role in reducing LDL oxidation in humans, which suggests that taking green tea catechins is effective in reducing atherosclerosis risk associated with oxidative stress.

Keywords: Epigallocatechin gallate; Humans; Lipid peroxidation; Lipoproteins; Low-density lipoprotein; Tea.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antioxidants / analysis
  • Antioxidants / metabolism
  • Antioxidants / therapeutic use*
  • Atherosclerosis / blood
  • Atherosclerosis / epidemiology
  • Atherosclerosis / metabolism
  • Atherosclerosis / prevention & control
  • Biomarkers / blood
  • Camellia sinensis / chemistry*
  • Catechin / analogs & derivatives*
  • Catechin / analysis
  • Catechin / metabolism
  • Catechin / therapeutic use
  • Cross-Over Studies
  • Dietary Supplements*
  • Double-Blind Method
  • Female
  • Humans
  • Japan / epidemiology
  • Lipoproteins, LDL / antagonists & inhibitors*
  • Lipoproteins, LDL / blood
  • Lipoproteins, LDL / chemistry
  • Lipoproteins, LDL / metabolism
  • Male
  • Middle Aged
  • Oxidation-Reduction
  • Plant Extracts / chemistry
  • Plant Extracts / metabolism
  • Plant Extracts / therapeutic use*
  • Plant Leaves / chemistry*
  • Risk Factors
  • Young Adult

Substances

  • Antioxidants
  • Biomarkers
  • Lipoproteins, LDL
  • Plant Extracts
  • oxidized low density lipoprotein
  • Catechin